Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Galectin-3 in septic acute kidney injury: a translational study

Fig. 1

CLP experimental strategy. All rats underwent CLP. Control group (n = 18) received normal drinking water, while two intervention groups received a Gal-3 inhibitor, PMCP, at 400 mg/kg/d and 1200 mg/kg/d 7 d prior to CLP. Following CLP, blood was drawn at baseline, 2, 8, and 24 h post-CLP for serum biochemical measurements

Back to article page